Sandy Van Hemelryck

Determining orthogonal chromatographic systems prior to the development of methods to characterise impurities in drug substances

Elke Van Gyseghem, Sandy Van Hemelryck, M. Daszykowski et al. · Journal of Chromatography A · 2003 · 72 citations

Pharmacy, Chemistry, Pharmaceutical Analysis +14

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

Maarten Timmers, Paulien Ravenstijn, Liwen Xi et al. · Journal of Psychopharmacology · 2018 · 63 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +12

Electrophoretic separation strategy for chiral pharmaceuticals using highly-sulfated and neutral cyclodextrins based dual selector systems

Nele Matthijs, Sandy Van Hemelryck, Mohamed Maftouh et al. · Analytica Chimica Acta · 2004 · 62 citations

Pharmacy, Chemical Engineering, Pharmaceutics +10

In vitro evaluation of poloxamer in situ forming gels for bedaquiline fumarate salt and pharmacokinetics following intramuscular injection in rats

Sandy Van Hemelryck, Jonatan Dewulf, Harm Niekus et al. · International Journal of Pharmaceutics X · 2019 · 40 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +13

Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis

An Van den Bergh, Sandy Van Hemelryck, Jan Bevernage et al. · Molecular Pharmaceutics · 2018 · 16 citations

Pharmacy, Pharmacokinetics, Pharmacology +17